Các chế phẩm điều trị IVIg chứa kháng thể chống HLA-E tự nhiên có khả năng phản ứng với các alen HLA-Ia (HLA-A/-B/-Cw)

Negi, 2007, Intravenous immunoglobulin: an update on the clinical use and mechanisms of action., J Clin Immunol, 27, 233, 10.1007/s10875-007-9088-9 Glotz, 1993, Suppression of HLA-specific alloantibodies by high-dose intravenous immunoglobulins (IVIg). A potential tool for transplantation of immunized patients., Transplantation, 56, 335, 10.1097/00007890-199308000-00015 Tyan, 1994, Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ., Transplantation, 57, 553, 10.1097/00007890-199402270-00014 Jordan, 1998, Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action., Transplantation, 66, 800, 10.1097/00007890-199809270-00017 Montgomery, 2000, Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients., Transplantation, 70, 887, 10.1097/00007890-200009270-00006 Nair, 2012, Effect of high-dose intravenous immunoglobulin on anti-HLA antibodies in sensitized kidney transplant candidates., Clin Transplant, 26, E261, 10.1111/j.1399-0012.2012.01657.x Alachkar, 2012, Infusion of high-dose intravenous immunoglobulin fails to lower the strength of human leukocyte antigen antibodies in highly sensitized patients., Transplantation, 94, 165, 10.1097/TP.0b013e318253f7b6 Marfo, 2012, Lack of effect in desensitization with intravenous immunoglobulin and rituximab in highly sensitized patients., Transplantation, 94, 345, 10.1097/TP.0b013e3182590d2e Tongio, 1985, Natural HLA antibodies., Tissue Antigens, 26, 271, 10.1111/j.1399-0039.1985.tb02225.x Luscher, 1998, Anti-HLA alloAb is found in children but does not correlate with a lack of HIV type 1 transmission from infected mothers., AIDS Res Hum Retroviruses, 14, 99, 10.1089/aid.1998.14.99 Morales-Buenrostro, 2008, “Natural” human leukocyte antigen antibodies found in nonalloimmunized healthy males., Transplantation, 86, 1111, 10.1097/TP.0b013e318186d87b Zhou, 2008, Existence of an immunoglobulin G component of naturally occurring HLA class I antibodies that are not directed against self-antigens in human serum., Tissue Antigens, 72, 98, 10.1111/j.1399-0039.2008.01074.x Ravindranath, 2010, Antibodies to HLA-E in nonalloimmunized males: pattern of HLA-Ia reactivity of anti-HLA-E-positive sera., J Immunol, 185, 1935, 10.4049/jimmunol.1000424 Ravindranath, 2010, HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: relevance to human natural HLA antibodies., Mol Immunol, 47, 1121, 10.1016/j.molimm.2009.10.024 Ravindranath, 2011, Anti-HLA-E mAb 3D12 mimics MEM-E/02 in binding to HLA-B and HLA-C alleles: Web-tools validate the immunogenic epitopes of HLA-E recognized by the antibodies., Mol Immunol, 48, 423, 10.1016/j.molimm.2010.09.011 Derré, 2006, Expression and release of HLA-E by melanoma cells and melanocytes: potential impact on the response of cytotoxic effector cells., J Immunol, 177, 3100, 10.4049/jimmunol.177.5.3100 Coupel, 2007, Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation., Blood, 109, 2806, 10.1182/blood-2006-06-030213 Ravindranath, 2012, Augmentation of anti-HLA-E antibodies with concomitant HLA-Ia reactivity in IFNγ-treated autologous melanoma cell vaccine recipients., J Immunotoxicol, 9, 282, 10.3109/1547691X.2011.645582 Ravindranath, 2012, Antibodies to HLA-E may account for the non-donor-specific anti-HLA class-Ia antibodies in renal and liver transplant recipients., Int Immunol, 24, 43, 10.1093/intimm/dxr094 Ward, 1999, Monoclonal Antibody Production A Report of the, 1 Sansonno, 1986, An enzyme-linked immunosorbent assay for the detection of autoantibodies to albumin., J Immunol Methods, 90, 131, 10.1016/0022-1759(86)90393-5 Pires, 2006, Naturally occurring anti-albumin antibodies are responsible for false positivity in diagnosis of autoimmune premature ovarian failure., J Histochem Cytochem, 54, 397, 10.1369/jhc.5A6778.2005 Hoppe, 1979, [Antibody screening of commercially available immunoglobulins. Erythrocyte-, HLA- and autoantibodies (author’s transl)]., Blut, 39, 9, 10.1007/BF01008070 Kaveri, 1996, Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use., J Clin Invest, 97, 865, 10.1172/JCI118488 Stoclin, 2013, Transfusion-related acute lung injury after intravenous immunoglobulin treatment in a lung transplant recipient., Vox Sang, 104, 175, 10.1111/j.1423-0410.2012.01645.x Ghio, 2000, The immunomodulatory effect of blood transfusions and intravenous immunoglobulins: the role of the soluble molecules of the Class-I major histocompatibility complex and of the Fas ligand., Ann Ital Med Int, 15, 70 Barocci, 1990, Anti-HLA antibodies (Ab1) and anti-idiotypic antibodies (Ab2) directed against Anti-HLA Ab1 in various preparations of polyspecific immunoglobulins for intravenous use., Boll Soc Ital Biol Sper, 66, 1193 Ott, 2001, Fc gamma RIIB as a potential molecular target for intravenous gamma globulin therapy., J Allergy Clin Immunol, 108, S95, 10.1067/mai.2001.117822 Heidt Sibéril, 2006, Selection of a human anti-RhD monoclonal antibody for therapeutic use: impact of IgG glycosylation on activating and inhibitory Fc γ R functions., Clin Immunol, 118, 170, 10.1016/j.clim.2005.10.008 Brinc, 2009;2009, Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn., Hematology (Am Soc Hematol Educ Program), (1), 185, 10.1182/asheducation-2009.1.185 Heyman, 2000, Regulation of antibody responses via antibodies, complement, and Fc receptors., Annu Rev Immunol, 18, 709, 10.1146/annurev.immunol.18.1.709 Uhr, 1968, Regulatory effect of antibody on the immune response., Adv Immunol, 8, 81, 10.1016/S0065-2776(08)60465-4 Santoso, 1992, Quantitation of soluble HLA class I antigen in human albumin and immunoglobulin preparations for intravenous use by solid-phase immunoassay., Vox Sang, 62, 29, 10.1159/000462159 Grosse-Wilde, 1992, Soluble HLA class I and class II concentrations in commercial immunoglobulin preparations., Tissue Antigens, 39, 74, 10.1111/j.1399-0039.1992.tb01910.x Blasczyk, 1993, Soluble CD4, CD8, and HLA molecules in commercial immunoglobulin preparations., Lancet, 341, 789, 10.1016/0140-6736(93)90563-V El-Awar, 2009, Epitopes of human leukocyte antigen class I antibodies found in sera of normal healthy males and cord blood., Hum Immunol, 70, 844, 10.1016/j.humimm.2009.06.020 Rizk, 2001, Transfusion-related acute lung injury after the infusion of IVIG., Transfusion, 41, 264, 10.1046/j.1537-2995.2001.41020264.x Dooren, 1998, Adult respiratory distress syndrome after experimental intravenous gamma-globulin concentrate and monocyte-reactive IgG antibodies., Lancet, 352, 1601, 10.1016/S0140-6736(05)61049-5 Berger-Achituv, 2008, Transfusion-related acute lung injury following intravenous anti-D administration in an adolescent., Am J Hematol, 83, 676, 10.1002/ajh.21185 Voulgari, 2010, Images in rheumatology. Transfusion-related acute lung injury during intravenous immunoglobulin treatment., J Rheumatol, 37, 190, 10.3899/jrheum.090725 Gupta, 2011, Transfusion related acute lung injury with intravenous immunoglobulin., Indian Pediatr, 48, 807 Newburger, 1986, The treatment of Kawasaki syndrome with intravenous gamma globulin., N Engl J Med, 315, 341, 10.1056/NEJM198608073150601 Lin, 2009, HLA-E gene polymorphism associated with susceptibility to Kawasaki disease and formation of coronary artery aneurysms., Arthritis Rheum, 60, 604, 10.1002/art.24261 Allard, 2011, Serum soluble HLA-E in melanoma: a new potential immune-related marker in cancer., PLoS ONE, 6, e21118, 10.1371/journal.pone.0021118 Pellegrino, 1982, Immunogenicity of serum HLA antigens in allogeneic combinations., Transplantation, 33, 530, 10.1097/00007890-198205000-00013